LexDanaLexDanabeta
New SessionSearchOfficial RankingsInsightsPricing
© LexDana · beta
LexDanaLexDanabeta
New SessionSearchOfficial RankingsInsightsPricing
LexDanaLexDanabeta

Insights

Analysis of patent litigation, PTAB practice, prosecution and pharma IP, written on the data behind LexDana.

AllCopyright & Trade Secrets59Federal Circuit877ITC / Section 33788Patent Litigation216Patent Prosecution126Pharma & ANDA62PTAB686Supreme Court61Trademark158USPTO Policy78Unsorted257

Tagged lawsuit · clear

PTAB

Patexia Insight 25: Apple Remains Number One IPR Petitioner in 2016 Despite the Drop in Litigation

A few weeks ago we reported a sharp decline in patent litigation in 2016 of more than 20 percent. However, activity for Inter-Partes Review (IPR) remained basically unchanged (1,638 challenges were filed in 2016). Some suggest that there is a 6- to…

January 24, 2017·PTAB·3 min read
Patent Litigation

Lawsuit against generic lidocaine patches

ACTION : Infringement of U.S. Patent 5,827,529 (referred to as “529 Patent) by Noven Therapeutics/ Noven Pharmaceuticals , makers of products such as the ADHD drug Daytrana, at a considerable harm to the transdermal drug delivery technology company…

August 14, 2012·Patent Litigation·3 min read
USPTO Policy

The Age of Patent Trolls: Either attack or hide!

Consider a hypothetical situation where the MD of ‘Techomigo’, a budding small software-technology company, receives a notice of infringement one fine afternoon and wonders what could be its cause since his company wasn’t involved in any…

July 26, 2011·USPTO Policy·4 min read
← NewerPage 3 of 3
LexDana
AskSearchRankingsInsightsPricingProfileContactTermsPrivacy
The LexDana Docket
Monthly — what shipped, who moved, what we published.
© 2026 LexDana, Inc.·Powered by Patexia data